[HTML][HTML] High-flow nasal oxygen: a safe, efficient treatment for COVID-19 patients not in an ICU
T Guy, A Créac'Hcadec, C Ricordel… - European …, 2020 - Eur Respiratory Soc
T Guy, A Créac'Hcadec, C Ricordel, A Salé, B Arnouat, JL Bizec, M Langelot, C Lineau…
European Respiratory Journal, 2020•Eur Respiratory Soc… This report describes the use of HFNO to manage SARS-CoV-2 infected patients with
respiratory failure on the pulmonology ward rather than in an ICU. 34 consecutive patients who
tested positive for COVID-19 by reverse transcriptase PCR were admitted to the respiratory
department. HFNO was systematically initiated when the … As the median incubation time is 5
days [8], is seems likely that using HFNO to treat COVID-19 patients requiring oxygen (>5 L·min
−1 ) was safe for healthcare workers at our institution. However, there is still a risk of …
respiratory failure on the pulmonology ward rather than in an ICU. 34 consecutive patients who
tested positive for COVID-19 by reverse transcriptase PCR were admitted to the respiratory
department. HFNO was systematically initiated when the … As the median incubation time is 5
days [8], is seems likely that using HFNO to treat COVID-19 patients requiring oxygen (>5 L·min
−1 ) was safe for healthcare workers at our institution. However, there is still a risk of …
SARS-CoV-2 infected patients with nonhypercapnic acute hypoxaemic respiratory failure can benefit from high-flow nasal oxygen outside an ICU. The technique appears to be safe for healthcare workers and could well liberate critical ICU resources.https://bit.ly/2Xq80iu
European Respiratory Society以上显示的是最相近的搜索结果。 查看全部搜索结果